Incyte (INCY) Total Liabilities (2010 - 2026)
Incyte (INCY) reported Total Liabilities of $1.7 billion for Q1 2026, down 17.56% on a YoY basis from $2.1 billion in Q1 2025, and down 4.15% quarter-over-quarter from $1.8 billion in Q4 2025.
Incyte (INCY) Total Liabilities (2010 - 2026) Analysis & Trends
Incyte has reported Total Liabilities for 17 years, with the latest figure at $1.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 17.56% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 17.56% YoY), and the FY2025 full-year result was $1.8 billion, down 10.33% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.7 billion, down from $1.8 billion in the prior quarter.
- The five-year high for Total Liabilities was $2.1 billion in Q1 2025, with the low at $1.2 billion in Q1 2022.
- Historically, Total Liabilities has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2025.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 30.43% — and 2026, when it retreated 17.56%.
- Incyte's Total Liabilities stood at $1.5 billion in 2022, then advanced by 8.25% to $1.6 billion in 2023, then rose by 25.4% to $2.0 billion in 2024, then dropped by 10.33% to $1.8 billion in 2025, then dropped by 4.15% to $1.7 billion in 2026.
- The last three Total Liabilities figures came in at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 1.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.65 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 1.84 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.47 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.28 Bn |
| Jun 30, 2022 | 1.23 Bn |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2021 | 1.16 Bn |
| Sep 30, 2021 | 1.05 Bn |
| Jun 30, 2021 | 968.76 Mn |